1[1]Thomssen R, Bonk S, Propfe C, et al. Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol (Berl), 1992,181: 293-300.
2[2]Thomssen R, Bonk S, Thiele A. Density bheterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins. Med Mierobiol Immunol (Berl), 1993,182: 329-334.
3[3]Prince AM, Huima-Byron T, Parker TS, et al. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepatitis, 1996,3:11-17.
4[4]Wunschmann S, Medlh JD, Klinzmann D, et al. Characterization of hepatitis C Virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol, 2000, 74:10055-10062.
5[5]Enjoji M, Nakamuta M, Kinukawa N, et al. Beta-lipoproteins influence the serum level of hepatitis C virus. Med Sci Monit, 2000,6:841-844.
6[6]Meyer K, Basu A, Ray R. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. Virology, 2000, 27:214-226.
7[7]Monazahian M, Kippenberger S, Muller A, et al. Binding of human lipoproteins (low, very how, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol (Berl), 2000,188:177-184.
8[8]Agnello V, Abel G, Elfahal M, et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA, 1999,96: 12766-12771.
9[9]Monazahian M, Bohme I, Bonk S, et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol,1999,57: 223-229.
10[10]Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type Ⅱ cryoglobulinemia. Arthritis Rheum, 1997,40:2007-2015.
